Ex-Home Diagnostics CEO faces insider trading charges

The former chairman, president and CEO of Home Diagnostics is facing insider trading charges from federal prosecutors and the Securities & Exchange Commission, accusing him of tipping off friends and family to Nipro's $215 million acquisition of the diabetes monitoring equipment maker last year. News

Suggested Articles

Digital molecule designer Insilico Medicine has launched a new preclinical research program focused on treatments for brain cancer.

Ortho Clinical Diagnostics has launched a new chemistry system to complete its integrated Vitros XT line of laboratory solutions.

Synthetic DNA weaver Twist Bioscience announced a handful of new collaborations this week amidst a $140 million raise from an underwritten offering.